BioAdvance News Novira Therapeutics Portfolio News

Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies

By WebmasterSeptember 4, 2014November 1st, 2024No Comments

Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies
Read more here

Previous PostRelmada Announces the Filing of Clinical Trial Application in Canada for D-Methadone
Next PostGalleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the Emerging Perioperative Sleep Apnea Epidemic

Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostRelmada Announces the Filing of Clinical Trial Application in Canada for D-Methadone

Next PostGalleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the Emerging Perioperative Sleep Apnea Epidemic